Insider · CIK 0001779614
Robert Lisicki
Files at ZURA (Zura Bio Ltd), CVKD (Cadrenal Therapeutics, Inc.). First filing -, latest -.
Robert Lisicki files SEC Form 4 as CEO and director at ZURA (Zura Bio Ltd), and also at CVKD (Cadrenal Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Lisicki has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | CVKD Cadrenal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +20,000 | $0.00 | $0 | 20,000 | Jan 24, 2025 |
| Dec 9, 2024 | ZURA Zura Bio Ltd | AGrant or award Employee Share Option (Right to Buy)derivative | +117,000 | $0.00 | $0 | 117,000 | Dec 11, 2024 |
Questions about Robert Lisicki
Answered from the filings on this page, as of the latest one.
Is Robert Lisicki buying or selling?
Robert Lisicki has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Lisicki's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Lisicki has 0.
Where does Robert Lisicki file Form 4?
Robert Lisicki has filed Form 4 at ZURA (Zura Bio Ltd) as Chief Executive Officer; CVKD (Cadrenal Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.